[{"address1": "1017 Ranch Road 620 South", "address2": "Suite 107", "city": "Lakeway", "state": "TX", "zip": "78734", "country": "United States", "phone": "512 598 0931", "website": "https://www.anebulo.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing treatments for unintentional cannabis poisoning, acute cannabinoid intoxication, and acute cannabis-induced conditions in the United States. The company's lead product candidate is the selonabant, a small-molecule antagonist of cannabinoid binding receptor type-1(CB1), which is in a phase II clinical trial to address the unmet medical need for a specific antidote for cannabis toxicity. Anebulo Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Lakeway, Texas.", "fullTimeEmployees": 2, "companyOfficers": [{"maxAge": 1, "name": "Dr. Joseph F. Lawler M.D., Ph.D.", "age": 53, "title": "Founder & Chairman", "yearBorn": 1972, "fiscalYear": 2025, "totalPay": 11000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Richard Anthony Cunningham", "age": 54, "title": "CEO & Director", "yearBorn": 1971, "fiscalYear": 2025, "totalPay": 461250, "exercisedValue": 0, "unexercisedValue": 8304}, {"maxAge": 1, "name": "Mr. Daniel V. George", "age": 55, "title": "Acting CFO & Secretary", "yearBorn": 1970, "fiscalYear": 2025, "totalPay": 208755, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Kenneth C. Cundy Ph.D.", "age": 66, "title": "Chief Scientific Officer", "yearBorn": 1959, "fiscalYear": 2025, "totalPay": 512467, "exercisedValue": 0, "unexercisedValue": 3020}], "compensationAsOfEpochDate": 1767139200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.19, "open": 1.1651, "dayLow": 1.11, "dayHigh": 1.1651, "regularMarketPreviousClose": 1.19, "regularMarketOpen": 1.1651, "regularMarketDayLow": 1.11, "regularMarketDayHigh": 1.1651, "payoutRatio": 0.0, "beta": -0.814, "forwardPE": -1.7538462, "volume": 36415, "regularMarketVolume": 36415, "averageVolume": 56134, "averageVolume10days": 83280, "averageDailyVolume10Day": 83280, "bid": 2.59, "ask": 2.39, "bidSize": 1, "askSize": 1, "marketCap": 46836592, "fiftyTwoWeekLow": 0.9, "fiftyTwoWeekHigh": 3.42, "allTimeHigh": 9.33, "allTimeLow": 0.8, "fiftyDayAverage": 2.08154, "twoHundredDayAverage": 1.901365, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 36481820, "profitMargins": 0.0, "floatShares": 3401405, "sharesOutstanding": 41084731, "sharesShort": 117022, "sharesShortPriorMonth": 116684, "sharesShortPreviousMonthDate": 1763078400, "dateShortInterest": 1765756800, "sharesPercentSharesOut": 0.0028, "heldPercentInsiders": 0.40537, "heldPercentInstitutions": 0.54083, "shortRatio": 7.3, "shortPercentOfFloat": 0.0168, "impliedSharesOutstanding": 41084731, "bookValue": 0.237, "priceToBook": 4.8101263, "lastFiscalYearEnd": 1751241600, "nextFiscalYearEnd": 1782777600, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -8442381, "trailingEps": -0.22, "forwardEps": -0.65, "52WeekChange": -0.21192056, "SandP52WeekChange": 0.18594909, "quoteType": "EQUITY", "currentPrice": 1.14, "recommendationKey": "none", "totalCash": 10354773, "totalCashPerShare": 0.252, "totalDebt": 0, "quickRatio": 10.754, "currentRatio": 10.931, "returnOnAssets": -0.86108, "returnOnEquity": -1.45109, "freeCashflow": -3372501, "operatingCashflow": -5932774, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "ANEB", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Anebulo Pharmaceuticals, Inc.", "longName": "Anebulo Pharmaceuticals, Inc.", "marketState": "CLOSED", "twoHundredDayAverageChangePercent": -0.40043077, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-05-07", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1620394200000, "postMarketChangePercent": -0.15788957, "postMarketPrice": 1.1382, "postMarketChange": -0.0017999411, "regularMarketChange": -0.05000007, "regularMarketDayRange": "1.11 - 1.1651", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 56134, "fiftyTwoWeekLowChange": 0.24000001, "fiftyTwoWeekLowChangePercent": 0.26666668, "fiftyTwoWeekRange": "0.9 - 3.42", "fiftyTwoWeekHighChange": -2.2800002, "fiftyTwoWeekHighChangePercent": -0.6666667, "fiftyTwoWeekChangePercent": -21.192057, "earningsTimestampStart": 1758744000, "earningsTimestampEnd": 1758744000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.22, "epsForward": -0.65, "fiftyDayAverageChange": -0.9415401, "fiftyDayAverageChangePercent": -0.4523286, "twoHundredDayAverageChange": -0.76136506, "corporateActions": [], "postMarketTime": 1767995499, "regularMarketTime": 1767992400, "exchange": "NCM", "messageBoardId": "finmb_673614867", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -4.2016864, "regularMarketPrice": 1.14, "displayName": "Anebulo Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2026-01-10"}]